FDA approves Bausch Health’s DUOBRII Halobetasol Propionate and Tazarotene lotion
The U.S. Food and Drug Administration (FDA) has approved the New Drug Application of Ortho Dermatologics' DUOBRII (halobetasol…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Apr 19
The U.S. Food and Drug Administration (FDA) has approved the New Drug Application of Ortho Dermatologics' DUOBRII (halobetasol…
25 Apr 19
For World Malaria Day, we profile five medical devices preventing the spread of malaria across the developing regions…
25 Apr 19
Phillips-Medisize, a Molex company, announces the Little Rock, Arkansas facility is fully compliant with the Current Good Manufacturing…
25 Apr 19
Biomedical innovation company Orchestra BioMed announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device…
24 Apr 19
Hill-Rom announced the U.S. Department of Defense (DoD) has granted Conditional Authority to Operate (ATO-C) its Welch AllynConnex…
24 Apr 19
BAROnova announced that the US Food and Drug Administration (FDA) has approved the TransPyloric Shuttle (TPS) Device, a…
24 Apr 19
Surmodics, a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced…
22 Apr 19
The US Food and Drug Administration (FDA) has granted approval for the first generic naloxone hydrochloride nasal spray,…
18 Apr 19
Cutera, a provider of laser, light and other energy-based aesthetic systems, announced that Canada’s healthcare regulatory authority Health…
16 Apr 19
Intact Vascular, a private medical device company, has received an approval from the US Food and Drug Administration…